Mapping the landscape of ovarian metastases of gastric cancer: insights, trends, and emerging perspectives
Research hotspots include multidisciplinary treatment (MDT), diagnostic tumor markers (e.g., CA125, CA19-9, and carcinoembryonic antigen (CEA)), imaging (e.g., MRI, ultrasound), and novel approaches such as immunotherapy and targeted therapy (Microsatellite Instability-High (MSI - H), Tumor Mutational Burden-High (TMB - H). Future directions call for multicenter clinical trials and interdisciplinary collaboration to improve patient outcomes.
Authors
- Tong Fu (ORCID: https://orcid.org/0000-0002-0596-6408)
- Xu Zhang (ORCID: https://orcid.org/0000-0003-3007-0061)
- Yuqing Chen (ORCID: https://orcid.org/0000-0002-9188-7406)
- Liping Wang (ORCID: https://orcid.org/0009-0009-1797-2563)
Institutions
- Jiangnan University (CN)
- Xuzhou Medical College (CN)
- Nantong University (CN)
- Soochow University (CN)
- Affiliated Hospital of Nantong University (CN)
- Zhangjiagang First People's Hospital (CN)
- Wuxi Fourth People's Hospital (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1186/s12957-025-04098-1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00